Stay updated on Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check17 days agoChange Detected- Version updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded Fallopian tube cancer to the conditions and updated the document revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check89 days agoChange DetectedPrimary peritoneal carcinoma was added to the study's conditions. The page revision indicates v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.